Close

Needham & Company Reiterates a 'Buy' on Aastrom Biosciences (ASTM); 2Q11/Early 3Q11 Review - Cell Therapy in the Sun Aug 16, 2011 07:40AM
Needham & Company Maintains a 'Buy' on Aastrom Biosciences (ASTM); SPA in the Summer Worth the Wait - Phase 3 Stem Cell Ixmyelocel-T Trial Jul 26, 2011 11:45AM
Needham & Company Maintains a 'Buy' on Aastrom Biosciences (ASTM); 12-Month Phase 2b RESTORE-CLI Data Further Demonstrate Consistent Safety and Efficacy Jun 2, 2011 07:46AM
Needham & Company Reiterates a 'Buy' on Aastrom Biosciences (ASTM); 1Q11/Early 2Q11 Review: Are We There Yet? May 17, 2011 07:40AM
After-Hours Movers 05/16: (GFRE) (PLAB) (WINN) Higher; (TXCC) (CDII) (HPQ) Lower May 16, 2011 06:10PM


Apr 4, 2011 10:47AM Notable Analyst Rating Changes 04/04: (F) (CAKE) (STI) Upgraded; (ENTG) (NDAQ) (NYX) Downgraded
Apr 4, 2011 10:17AM Morning Movers 04/04: (MSSR) (OREX) (VVUS) Higher; (AMIE) (DGW) Lower
Apr 4, 2011 07:26AM Needham & Company Starts Aastrom Biosciences (ASTM) at Buy; Platform in Autologous Stem Cells, Late-Stage Product in Critical Limb Ischemia
Dec 9, 2010 04:08PM Aastrom Biosciences (ASTM) Anounces Proposed Common Offering